BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 38750432)

  • 1. Diagnostic accuracy and cellular origin of pleural fluid CXCR3 ligands for tuberculous pleural effusion.
    Yan Z; Wen JX; Niu Y; Jiang TW; Huang JH; Chen H; Chen Q; Wang YF; Yan L; Hu ZD; Zheng WQ
    Cytokine; 2024 Jul; 179():156618. PubMed ID: 38663252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in
    Xie T; Wang Q; Gao J; He K; Yu J
    Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 Jun; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced differential evolution algorithm for feature selection in tuberculous pleural effusion clinical characteristics analysis.
    Zhou X; Chen Y; Gui W; Heidari AA; Cai Z; Wang M; Chen H; Li C
    Artif Intell Med; 2024 Jul; 153():102886. PubMed ID: 38749310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculous pleuritis: clinical presentations and diagnostic challenges.
    Chan KKP; Lee YCG
    Curr Opin Pulm Med; 2024 May; 30(3):210-216. PubMed ID: 38323466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aetiology of pleural effusions in children living in a high TB endemic setting.
    Wordui S; Masu A; Golden L; Chaya S; Reichmuth K; Visagie A; Ayuk A; Owusu SK; Marangu D; Affendi N; Lakhan A; Gray D; Vanker A; Zar HJ; Zampoli M
    Int J Tuberc Lung Dis; 2024 Jun; 28(6):295-300. PubMed ID: 38822478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the basics-risk factor identification of pediatric malignant lymphadenopathy proven by pathological studies.
    Su WH; Wu CC; Chou CM; Huang SY; Chen HC
    Pediatr Neonatol; 2024 May; 65(3):255-259. PubMed ID: 37980275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.
    Zhao T; Zhang J; Zhang X; Wang C
    BMC Pulm Med; 2024 May; 24(1):241. PubMed ID: 38750432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a prediction model for tuberculous pleural effusion: a large cohort study and external validation.
    Liu Y; Liang Z; Yuan S; Wang S; Guo F; Peng W; Yang J; Wu A
    Respir Res; 2022 May; 23(1):134. PubMed ID: 35624515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the quantification of adenosine deaminase and determination of the lactate dehydrogenase/adenosine deaminase ratio for the diagnosis of pleural tuberculosis in children and adolescents.
    Vieira JL; Foschiera L; Ferreira ICS; Chakr VCBG
    J Bras Pneumol; 2021; 47(2):e20200558. PubMed ID: 34008761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.
    Ren Z; Xu L
    Clinics (Sao Paulo); 2021; 76():e2515. PubMed ID: 33909825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.
    Lin L; Li S; Xiong Q; Wang H
    BMC Pulm Med; 2021 Mar; 21(1):95. PubMed ID: 33740937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of Pleural Fluid Lactate Dehydrogenase to Adenosine Deaminase Ratio in Pleural Tuberculosis.
    Beukes A; Shaw JA; Diacon AH; Irusen EM; Koegelenberg CFN
    Respiration; 2021; 100(1):59-63. PubMed ID: 33333531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.
    Lee J; Park JE; Choi SH; Seo H; Lee SY; Lim JK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Korean J Intern Med; 2022 Jan; 37(1):137-145. PubMed ID: 33045810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADA activity is decreased in lymphocytes from patients with advanced stage of lung cancer.
    Zanini D; Manfredi LH; Pelinson LP; Pimentel VC; Cardoso AM; Carmo Araújo Gonçalves VD; Santos CBD; Gutierres JM; Morsch VM; Leal DBR; Schetinger MRC
    Med Oncol; 2019 Aug; 36(9):78. PubMed ID: 31375946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and potential indicators for definite diagnosis of tuberculous pleural effusion.
    Yang X; Feng M; Shen Y; Deng B; He Y; Cao G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1924-1931. PubMed ID: 31096801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
    Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
    Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis.
    Aggarwal AN; Agarwal R; Sehgal IS; Dhooria S
    PLoS One; 2019; 14(3):e0213728. PubMed ID: 30913213
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.